Last update 01 Nov 2024

MPC2 x L-lactate dehydrogenase x MPC1

Basic Info

Related Targets
MPC2L-lactate dehydrogenaseMPC1

Related

1
Drugs associated with MPC2 x L-lactate dehydrogenase x MPC1
PP-405(Pelage Pharmaceuticals)
Target
L-lactate dehydrogenase x MPC1 x MPC2
Mechanism
L-lactate dehydrogenase stimulants [+2]
Active Org.
Pelage Pharmaceuticals, Inc.Pelage Pharmaceuticals, Inc.
Originator Org.
Pelage Pharmaceuticals, Inc.Pelage Pharmaceuticals, Inc.
Active Indication
Androgenetic Alopecia
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with MPC2 x L-lactate dehydrogenase x MPC1
NCT06393452 / Active, not recruitingPhase 2
A Randomized, Multicenter, Double-blind, Vehicle-controlled, Phase 2a Study to Assess the Safety, Pharmacokinetics, and Efficacy of PP405 in Adults With Androgenetic Alopecia
100 Clinical Results associated with MPC2 x L-lactate dehydrogenase x MPC1
Login to view more data
100 Translational Medicine associated with MPC2 x L-lactate dehydrogenase x MPC1
Login to view more data
0 Patents (Medical) associated with MPC2 x L-lactate dehydrogenase x MPC1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free